These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1553894)

  • 1. Safety of bepridil: from review of the European data.
    Coumel P
    Am J Cardiol; 1992 Apr; 69(11):75D-78D. PubMed ID: 1553894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bepridil and torsades de pointes: are the precautions of use respected?].
    Viallon A; Page Y; Lafond P; Guy C; Cusey I; Tardy B; Zeni F; Lapierre B; Bertrand JC
    Therapie; 1994; 49(5):431-4. PubMed ID: 7855758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bepridil therapy: guidelines for patient selection and monitoring of therapy.
    Singh BN
    Am J Cardiol; 1992 Apr; 69(11):79D-85D. PubMed ID: 1553895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety profile of bepridil determined from clinical trials in chronic stable angina in the United States.
    Singh BN
    Am J Cardiol; 1992 Apr; 69(11):68D-74D. PubMed ID: 1532469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bepridil: importance of serum level in treatment surveillance].
    Viallon A; Laporte-Simitsidis S; Pouzet V; Venet C; Tardy B; Zéni F; Bertrand JC
    Presse Med; 2000 Apr; 29(12):645-7. PubMed ID: 10780196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and safety of bepridil and diltiazem in chronic stable angina pectoris refractory to diltiazem. The Bepridil Collaborative Study Group.
    Singh BN
    Am J Cardiol; 1991 Aug; 68(4):306-12. PubMed ID: 1858672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes.
    Campens D
    Anesth Analg; 1996 Oct; 83(4):887. PubMed ID: 8831345
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of bepridil on cardiac electrophysiologic properties.
    Prystowsky EN
    Am J Cardiol; 1992 Apr; 69(11):63D-67D. PubMed ID: 1553893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes caused by Mibefradil.
    Gläser S; Steinbach M; Opitz C; Wruck U; Kleber FX
    Eur J Heart Fail; 2001 Oct; 3(5):627-30. PubMed ID: 11595612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone.
    Takahara A; Nakamura Y; Sugiyama A
    Eur J Pharmacol; 2008 Oct; 596(1-3):127-31. PubMed ID: 18786527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of sick sinus syndrome that developed torsades de pointes, pacing failure and sensing failure during administration of bepridil.
    Ohsawa M; Tanaka F; Kunugita F; Saito H; Nakamura M; Shiroto T; Hotta K; Chiba N; Hiramori K
    Jpn Heart J; 2003 Sep; 44(5):783-8. PubMed ID: 14587660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion.
    Shimano K; Chang K; Hara Y; Yasuda A; Sawamura S
    JA Clin Rep; 2021 Oct; 7(1):76. PubMed ID: 34643822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic and proarrhythmic properties of QT-prolonging antianginal drugs.
    Singh BN; Wadhani N
    J Cardiovasc Pharmacol Ther; 2004 Sep; 9 Suppl 1():S85-97. PubMed ID: 15378133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Torsades de Pointes after Ondansetron Infusion in 2 Patients.
    Lee DY; Trinh T; Roy SK
    Tex Heart Inst J; 2017 Oct; 44(5):366-369. PubMed ID: 29259513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone and torsades de pointes in patients with advanced heart failure.
    Middlekauff HR; Stevenson WG; Saxon LA; Stevenson LW
    Am J Cardiol; 1995 Sep; 76(7):499-502. PubMed ID: 7653452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of bepridil versus placebo in angina pectoris: treatment and withdrawal studies.
    Shapiro W
    Am J Cardiol; 1992 Apr; 69(11):43D-49D. PubMed ID: 1553891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome.
    Johansson M; Carlsson L
    J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bepridil hydrochloride compared with placebo in patients with stable angina pectoris.
    Narahara KA; Singh BN; Karliner JS; Corday SR; Hossack KF
    Am J Cardiol; 1992 Apr; 69(11):37D-42D. PubMed ID: 1553890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.